Deal-making sentiment seems to have emerged stronger out of the downturn as M&A activity reached a record high during 2021. The momentum set in towards the end of 2020, continued through 2021 with all the quarters reporting deals with a cumulative value of around $1 trillion across the year.While most deals-based analyses focus on the win or lose for deal participants, GlobalData's League Tables provide you with insights on the pharma players benefitting from these M&A volumes. The deal types covered in our report include:
Private equity buyouts
Use our report to understand your company’s performance across target regions and get insight into the volumes your competitors are able to generate in your markets of focus.
Thank you.Please check your email to download the white paper.